Cargando…
SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876838/ https://www.ncbi.nlm.nih.gov/pubmed/35215217 http://dx.doi.org/10.3390/pathogens11020275 |
_version_ | 1784658267775959040 |
---|---|
author | Khamees, Almu’atasim Bani-Issa, Jamal Zoubi, Mazhar Salim Al Qasem, Taqwa AbuAlArjah, Manal Issam Alawadin, Sura Ahmad Al-Shami, Khayry Hussein, Farah E. Hussein, Emad Bashayreh, Ibrahim H. Tambuwala, Murtaza M. Al-Saghir, Mohannad Cornelison, Christopher T. |
author_facet | Khamees, Almu’atasim Bani-Issa, Jamal Zoubi, Mazhar Salim Al Qasem, Taqwa AbuAlArjah, Manal Issam Alawadin, Sura Ahmad Al-Shami, Khayry Hussein, Farah E. Hussein, Emad Bashayreh, Ibrahim H. Tambuwala, Murtaza M. Al-Saghir, Mohannad Cornelison, Christopher T. |
author_sort | Khamees, Almu’atasim |
collection | PubMed |
description | COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries. |
format | Online Article Text |
id | pubmed-8876838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88768382022-02-26 SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants Khamees, Almu’atasim Bani-Issa, Jamal Zoubi, Mazhar Salim Al Qasem, Taqwa AbuAlArjah, Manal Issam Alawadin, Sura Ahmad Al-Shami, Khayry Hussein, Farah E. Hussein, Emad Bashayreh, Ibrahim H. Tambuwala, Murtaza M. Al-Saghir, Mohannad Cornelison, Christopher T. Pathogens Review COVID-19 is caused by a novel coronavirus (2019-nCoV), which was declared as a pandemic after it emerged in China 2019. A vast international effort has been conducted to prevent and treat COVID-19 due to its high transmissibility and severe morbidity and mortality rates, particularly in individuals with chronic co-morbidities. In addition, polymorphic variants increased the need for proper vaccination to overcome the infectivity of new variants that are emerging across the globe. Many treatment options have been proposed and more than 25 vaccines are in various stages of development; however, the infection peaks are oscillating periodically, which raises a significant question about the effectiveness of the prevention measures and the persistence of this pandemic disease. In this review, we are exploring the most recent knowledge and advances in the treatment and vaccination options as well as the new emerging variants of 2019-nCoV and the possible mitigation of one of the most aggressive pandemics in the last centuries. MDPI 2022-02-20 /pmc/articles/PMC8876838/ /pubmed/35215217 http://dx.doi.org/10.3390/pathogens11020275 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khamees, Almu’atasim Bani-Issa, Jamal Zoubi, Mazhar Salim Al Qasem, Taqwa AbuAlArjah, Manal Issam Alawadin, Sura Ahmad Al-Shami, Khayry Hussein, Farah E. Hussein, Emad Bashayreh, Ibrahim H. Tambuwala, Murtaza M. Al-Saghir, Mohannad Cornelison, Christopher T. SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title | SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title_full | SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title_fullStr | SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title_full_unstemmed | SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title_short | SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants |
title_sort | sars-cov-2 and coronavirus disease mitigation: treatment options, vaccinations and variants |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876838/ https://www.ncbi.nlm.nih.gov/pubmed/35215217 http://dx.doi.org/10.3390/pathogens11020275 |
work_keys_str_mv | AT khameesalmuatasim sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT baniissajamal sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT zoubimazharsalimal sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT qasemtaqwa sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT abualarjahmanalissam sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT alawadinsuraahmad sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT alshamikhayry sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT husseinfarahe sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT husseinemad sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT bashayrehibrahimh sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT tambuwalamurtazam sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT alsaghirmohannad sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants AT cornelisonchristophert sarscov2andcoronavirusdiseasemitigationtreatmentoptionsvaccinationsandvariants |